Imperial College London

MissKanikaDharmayat

Faculty of MedicineSchool of Public Health

Research Postgraduate
 
 
 
//

Contact

 

+44 (0)20 7594 9988kanika.dharmayat13

 
 
//

Location

 

Reynolds BuildingCharing Cross Campus

//

Summary

 

Summary

Kanika is a Research Assistant in the Imperial Centre for Cardiovascular Disease Prevention unit within the School of Public Health. She has studied Physiology and Pharmacology (BSc) at University of Leicester and Public Health (MPH) at Imperial College London. Her previous project work include: the Manicaland study, Supporting LIFE and various Randomised Clinical Trials at the Neuroepidemiology and Aging unit. Currently, her research areas of focus are in the contribution of digital health and Big Data to the study of cardiovascular disease. 

Publications

Journals

El Asmar ML, Dharmayat K, Vallejo-Vaz AJ, et al., 2021, Effect of computerised, knowledge-based, clinical decision support systems on patient-reported and clinical outcomes of patients with chronic disease managed in primary care settings: a systematic review, Bmj Open, Vol:11, ISSN:2044-6055, Pages:1-14

Vallejo-Vaz AJ, Stevens CAT, Lyons ARM, et al., 2021, Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), The Lancet, Vol:398, ISSN:0140-6736, Pages:1713-1725

Chirambo GB, Thompson M, Hardy V, et al., 2021, Effectiveness of smartphone-based community case management on the urgent referral, reconsultation, and hospitalization of children aged under 5 years in Malawi: cluster-randomized, stepped-wedge trial, Journal of Medical Internet Research, Vol:23, ISSN:1438-8871, Pages:1-11

Watkinson F, Dharmayat K, Mastellos N, 2021, A mixed-method service evaluation of health information exchange in England: technology acceptance and barriers and facilitators to adoption, Bmc Health Services Research, Vol:21, ISSN:1472-6963, Pages:1-13

Brandts J, Dharmayat KI, Vallejo-Vaz AJ, et al., 2021, A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia, Atherosclerosis, Vol:325, ISSN:0021-9150, Pages:46-56

More Publications